Ronald L. P. van Vlierberghe

Cancer-immune interactions in ER-positive breast cancers: PI3K pathway alterations and tumor-infiltrating lymphocytes

Marcelo Sobral‐Leite, Izhar Salomon, Mark Opdam et al. · Breast Cancer Research · 2019 · 127 citations · Full text

Expression of HLA Class I Antigen, Aspirin Use, and Survival After a Diagnosis of Colon Cancer

Marlies S. Reimers, Esther Bastiaannet, Ruth E. Langley et al. · JAMA Internal Medicine · 2014 · 112 citations

The Phenotypic Heterogeneity of Human Natural Killer Cells: Presence of at least 48 Different Subsets in the Peripheral Blood

Liesbeth E. Jonges, Per Albertsson, Ronald L. P. van Vlierberghe et al. · Scandinavian Journal of Immunology · 2001 · 71 citations

The prognostic and predictive value of Tregs and tumor immune subtypes in postmenopausal, hormone receptor-positive breast cancer patients treated with adjuvant endocrine therapy: a Dutch TEAM study analysis

C.C. Engels, Ayoub Charehbili, Cornelis J.�H. van de Velde et al. · Breast Cancer Research and Treatment · 2015 · 46 citations · Full text

The development of novel mouse monoclonal antibodies against the CC531 rat colon adenocarcinoma

Martin Hagenaars, Ron Koelemij, N. Geeske Ensink et al. · Clinical & Experimental Metastasis · 2000 · 27 citations